Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Staff Expansion May Help With New Medicare Rx Broker Baucus

Executive Summary

PhRMA's federal affairs staff expansion includes a timely addition that should help the trade association work with incoming Finance Committee Chairman Baucus (D-Mont.).

You may also be interested in...



Amgen Adds Two More PhRMA Lobbyists To D.C. Office

Amgen's D.C. office is adding two more lobbyists from the Pharmaceutical Research & Manufacturers of America federal affairs team

Amgen Adds Two More PhRMA Lobbyists To D.C. Office

Amgen's D.C. office is adding two more lobbyists from the Pharmaceutical Research & Manufacturers of America federal affairs team

Medicare Rx Mark Up In July Remains Finance Cmte. Goal Under Baucus

Incoming Senate Finance Committee Chairman Baucus (D-Mont.) hopes to stick to the planned schedule to mark up Medicare prescription drug legislation during July, Finance Committee Democratic Counsel Elizabeth Fowler, PhD, told an Alliance for Health Reform briefing May 30 in Washington, D.C.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel